comparemela.com

Latest Breaking News On - Afshin salsali - Page 1 : comparemela.com

Empagliflozin may reduce serum uric acid in HF patients, lower mortality risk: EMPEROR-reduced trial

Germany: In patients with heart failure, hyperuricemia is a common comorbidity and is an independent predictor of advanced disease severity and increased mortality, the researchers state in a study.

Pedro ferreiraAugustenburger platzCarolyn kaempferMilton packerAfshin salsaliJamesl januzziWolfram doehnerGerasimos filippatosMartina brueckmannFaiez zannadJaved butlerStuartj pocockStefand ankerBerlin institute of health centerEuropean heartBerlin institute

Adults With Acute Heart Failure Benefit When Treated With a Type 2 Diabetes Medication

EMPULSE Trial showed hospitalized adults taking empagliflozin had reduced rates of death or re-hospitalization due to acute heart failure

United statesPedro ferreiraJohnr teerlinkMitchell psotkaJonp blatchfordAfshin salsaliMartina brueckmannChristianee angermannAdriaan voorsPiotr ponikowskiMichaele nassifMikhailn kosiborodJan biegasSeanp collinsEli lilly companyBoehringer ingelheim

vimarsana © 2020. All Rights Reserved.